NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals. Our technology targets two special cellular components known as organelles that harbor their own DNA. Those organelles are called mitochondria and chloroplasts. Both organelles are important to create energy for cells to grow. They are also critical for producing various biochemical molecules key to specific pathways and functions. Our genome technology has broad application areas. They range from industrial biotechnology to animal and human healthcare as well as to agriculture. Our mission is to harness the potentials of organelles to make our society a better place to live.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Wilmington, De 19803, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- napigen.com
- Keywords
- Philadelphia.
- HQ
- Wilmington, DE
Napigen, Inc. Questions
Napigen, Inc.'s website is napigen.com
Napigen, Inc.'s LinkedIn profile is https://www.linkedin.com/company/napigen
Napigen, Inc. has
22 employees.
View email and phone details for 22
employees at Napigen, Inc..
Napigen, Inc.'s industry is
Biotechnology Research
Napigen, Inc.'s top competitors are
Sindri Materials Corp.,
The Grantham Foundation For The Protection Of The Environment,
The Innovation Space,
Synnovation Therapeutics,
Newleaf Symbiotics, Inc.,
Carlisle Companies Incorporated,
Unsmudgeable,
Carbon Reform,
Nikang Therapeutics Inc.,
Pluton Biosciences.
Napigen, Inc.'s categories are Biotechnology Research
Napigen, Inc.'s founding year is 2016
